Archives: Morning Breakouts
761-780 of 112,920 results
-
-
Viewpoints: Is It Ethical For Young Kids To Take GLP-1s?; AI In Medicine Is A Tool, Not A Replacement
Opinion writers tackle these public health issues.
By khnelysiag -
EpiPen Makers Agree To $4.5M Deal With Maryland Over Its Pricing, Marketing
The settlement comes after the makers were accused of using a monopoly to increase prices, requiring injectors to be purchased in a two-pack, and restricting generic versions of the EpiPen.
By khnlaureno -
AI Deepfakes Are Using Doctors’ Likenesses To Promote Dubious Products, Misinformation
Physicians are calling for stricter laws governing AI in the wake of a slew of deepfake videos circulating on social media. Doctors worry that it could contribute to the ongoing erosion of public trust in the medical establishment, and even to insurance fraud, Axios reports.
By khnlaureno -
While Courts Hash Out Mifepristone Case, Providers Eye Misoprostol For Abortion Care
If the Supreme Court rules that mifepristone can't be prescribed via telehealth or dispensed by mail, providers say, misoprostol alone has been found to be a safe and effective method for ending pregnancies. Some countries already rely on misoprostol for abortion care.
By khnlaureno -
2 Cruise Ship Hantavirus Victims Had ‘Andes’ Strain That Spreads From Person To Person
Health officials in South Africa confirmed the findings. Meanwhile, a battle over where to dock the MV Hondius continued Wednesday morning.
By khnlaureno -
FDA OKs First Fruit-Flavored Vapes For Adults 21 And Older
The move marks a shift after years of efforts by the FDA to regulate flavored vapes and just after The Wall Street Journal reported that President Donald Trump pushed for the approval, The Washington Post reports.
By khnlaureno -
Feds Kept Favorable Studies On Covid, Shingles Vaccines Under Wraps, HHS Confirms
Scientists combed millions of patient records and determined that serious side effects from the covid and shingles shots are rare. The Trump administration withdrew the publication of those studies. Although HHS said "the authors drew broad conclusions that were not supported by the underlying data," career scientists who reviewed the drafts say the studies were well done.
By khnlaureno -
First Edition: Wednesday, May 6, 2026
Today's early morning highlights from the major news organizations.
By khnlaureno -
Viewpoints: Mifepristone Ruling Makes Drug Development Tricky; Hantavirus Outbreak Shows Risk Of WHO Absence
Editorial writers discuss these public health topics.
By khnelysiag -
Social Media Videos Are Exposing Teens To Inhalant Use, Study Shows
A recent study published in the Journal of Studies on Alcohol and Drugs looked at the prevalence of videos about nitrous oxide circulating on social media platforms without any health warnings or age restrictions, HealthDay reported.
By khnlaureno -
Two Measles Cases Emerge In South Carolina After Outbreak Ends
The cases are not linked to the outbreak, which was declared over April 26. Health officials say 39 people will remain in quarantine through Saturday. Also: Wyoming reports its first measles case of 2026; Minnesota farmers are seeking mental health help; and more.
By khnlaureno -
FDA Allows Early Access To Experimental Pancreatic Cancer Drug
In clinical trials, daraxonrasib has been shown to double the average survival time for patients who had received conventional treatments, HealthDay reports. Other pharmaceutical news is about IBD therapy, GLP-1s, "skinny labels," and more.
By khnlaureno -
Feds Investigate Mass. Women’s College For Allowing ‘Biological Men’
In its fight against trans people, the Trump administration on Monday launched a Title IX probe of Smith College, a 155-year-old liberal arts college in Northampton, Massachusetts. The Department of Education blasted the school for "granting [transgender people] access to women-only spaces." Smith College told CNN it “is fully committed to its institutional values, including compliance with civil rights laws."
By khnlaureno -
UnitedHealth Group Says It Will Slash Pre-Authorizations By 30%
The Wall Street Journal reported that the insurance giant will stop requiring pre-authorizations for certain things, including echocardiograms, some outpatient surgeries, some outpatient therapy, and some chiropractic care. It will use AI-assisted tech to reduce the need for preapprovals, the insurer said.
By khnlaureno -
Mail-Order Mifepristone Access Restored For A Week, Sowing Confusion
The Supreme Court has temporarily lifted a lower court's order to halt the prescribing of abortion pills via telehealth and dispensing them by mail. Even in states where abortion is legal, the off-and-on court rulings have left providers scrambling to get patients the care they seek.
By khnlaureno -
First Edition: Tuesday, May 5, 2026
Today's early morning highlights from the major news organizations.
By khnlaureno -
Viewpoints: Are The ‘Blue Zones’ A Fraud?; Oversight Is Necessary For FDA’s Fast-Track Of Psychedelics
Opinion writers tackle these public health topics.
By khnelysiag -
Suspected Hantavirus Outbreak On Cruise Ship Kills 3, Sickens At Least 3 Others
CNN reported that the three who died were cruise passengers on the MV Hondius, said Oceanwide Expeditions, the company that operates the ship. It's currently anchored at Cape Verde, off the west coast of Africa. Passengers won't be allowed to disembark, the country's health minister said.
By khnlaureno -
After Merger, New Hampshire’s Exeter Hospital Struggles To Maintain Standard Of Care, Patients Say
Exeter Health Resources in 2023 merged with Beth Israel Lahey Health, which had pledged to maintain and expand access to clinical services. But in 2024, cuts were made to pediatric dental care, neurology, podiatry, and the advanced life support paramedic intercept service, The Portsmouth Herald reported.
By khnlaureno